Compugen (CGEN) Director Livnat Savitzky Kinneret Receives Awards

What Happened
Livnat Savitzky Kinneret, a director of Compugen Ltd (CGEN), received two equity awards on 2026-07-29: 7,500 restricted stock units (RSUs) and a 10,000-share derivative option grant. Both transactions are reported as acquisitions at $0.00 (i.e., awards/compensation), not open-market purchases or sales.

Key Details

• Transaction date: 2026-07-29; Form 4 filed 2026-07-30 (not reported as late).
• Awards and amounts: 7,500 RSUs (F1) and 10,000 share-equivalent option/derivative (F2). Reported acquisition price: $0.00 for both.
• Vesting: RSUs vest 25% on Oct 1, 2027, with the remainder vesting in 12 equal quarterly installments thereafter (F1). The option follows the same 25% on Oct 1, 2027, then 12 equal quarterly installments (F2).
• Shares owned after transaction: not disclosed in the provided filing details.
• Transaction code: A (award/grant). No indica­tion of a 10b5-1 plan, tax-withholding sale, or immediate exercise/sale in the filing.

Context
These awards are compensation grants subject to multi-year vesting and do not represent an immediate market purchase or sale. RSUs convert to shares upon vesting; the option/derivative will vest according to the schedule in F2 and may require exercise steps later (exercise price not stated in the provided summary). Awards like these are common for alignment with company performance and retention and should be viewed as compensation rather than an immediate trading signal.